在医疗保健公共政策中使用成本效益阈值:进展与挑战》。

IF 3.1 4区 医学 Q1 ECONOMICS Applied Health Economics and Health Policy Pub Date : 2024-07-12 DOI:10.1007/s40258-024-00900-5
Oscar Espinosa, Paul Rodríguez-Lesmes, Giancarlo Romano, Esteban Orozco, Sergio Basto, Diego Ávila, Lorena Mesa, Hernán Enríquez
{"title":"在医疗保健公共政策中使用成本效益阈值:进展与挑战》。","authors":"Oscar Espinosa,&nbsp;Paul Rodríguez-Lesmes,&nbsp;Giancarlo Romano,&nbsp;Esteban Orozco,&nbsp;Sergio Basto,&nbsp;Diego Ávila,&nbsp;Lorena Mesa,&nbsp;Hernán Enríquez","doi":"10.1007/s40258-024-00900-5","DOIUrl":null,"url":null,"abstract":"<div><p>The article offers a comparative analysis of the influence of cost-effectiveness thresholds in the decision-making processes in financing policies, coverage, and price regulation of health technologies in nine countries. We investigated whether countries used cost-effectiveness thresholds for public health policy decision making and found that few countries have adopted the cost-effectiveness threshold as an official criterion for financing, reimbursement, or pricing. However, in countries where it is applied, such as Thailand, the results have been very favorable in terms of minimizing health technology prices and ensuring the financial sustainability of the health system. Although the cost-effectiveness threshold has opportunities for improvement, particularly in certain institutional contexts and with adequate participation of the different strategic actors in the formulation of public policy, its potential use and added value are significant in various aspects.</p></div>","PeriodicalId":8065,"journal":{"name":"Applied Health Economics and Health Policy","volume":"22 6","pages":"797 - 804"},"PeriodicalIF":3.1000,"publicationDate":"2024-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s40258-024-00900-5.pdf","citationCount":"0","resultStr":"{\"title\":\"Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges\",\"authors\":\"Oscar Espinosa,&nbsp;Paul Rodríguez-Lesmes,&nbsp;Giancarlo Romano,&nbsp;Esteban Orozco,&nbsp;Sergio Basto,&nbsp;Diego Ávila,&nbsp;Lorena Mesa,&nbsp;Hernán Enríquez\",\"doi\":\"10.1007/s40258-024-00900-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The article offers a comparative analysis of the influence of cost-effectiveness thresholds in the decision-making processes in financing policies, coverage, and price regulation of health technologies in nine countries. We investigated whether countries used cost-effectiveness thresholds for public health policy decision making and found that few countries have adopted the cost-effectiveness threshold as an official criterion for financing, reimbursement, or pricing. However, in countries where it is applied, such as Thailand, the results have been very favorable in terms of minimizing health technology prices and ensuring the financial sustainability of the health system. Although the cost-effectiveness threshold has opportunities for improvement, particularly in certain institutional contexts and with adequate participation of the different strategic actors in the formulation of public policy, its potential use and added value are significant in various aspects.</p></div>\",\"PeriodicalId\":8065,\"journal\":{\"name\":\"Applied Health Economics and Health Policy\",\"volume\":\"22 6\",\"pages\":\"797 - 804\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-07-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://link.springer.com/content/pdf/10.1007/s40258-024-00900-5.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Applied Health Economics and Health Policy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s40258-024-00900-5\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ECONOMICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Health Economics and Health Policy","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s40258-024-00900-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 0

摘要

文章比较分析了成本效益阈值在九个国家卫生技术的融资政策、覆盖范围和价格监管决策过程中的影响。我们调查了各国是否在公共卫生政策决策中使用成本效益阈值,发现很少有国家将成本效益阈值作为融资、报销或定价的官方标准。然而,在泰国等采用成本效益阈值的国家,在最大限度地降低医疗技术价格和确保医疗系统的财务可持续性方面取得了非常好的效果。尽管成本效益阈值还有改进的余地,特别是在某些体制背景下,以及在不同战略行动者充分参与公共政策制定的情况下,但其潜在用途和附加值在各个方面都具有重要意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges

The article offers a comparative analysis of the influence of cost-effectiveness thresholds in the decision-making processes in financing policies, coverage, and price regulation of health technologies in nine countries. We investigated whether countries used cost-effectiveness thresholds for public health policy decision making and found that few countries have adopted the cost-effectiveness threshold as an official criterion for financing, reimbursement, or pricing. However, in countries where it is applied, such as Thailand, the results have been very favorable in terms of minimizing health technology prices and ensuring the financial sustainability of the health system. Although the cost-effectiveness threshold has opportunities for improvement, particularly in certain institutional contexts and with adequate participation of the different strategic actors in the formulation of public policy, its potential use and added value are significant in various aspects.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Applied Health Economics and Health Policy
Applied Health Economics and Health Policy Economics, Econometrics and Finance-Economics and Econometrics
CiteScore
6.10
自引率
2.80%
发文量
64
期刊介绍: Applied Health Economics and Health Policy provides timely publication of cutting-edge research and expert opinion from this increasingly important field, making it a vital resource for payers, providers and researchers alike. The journal includes high quality economic research and reviews of all aspects of healthcare from various perspectives and countries, designed to communicate the latest applied information in health economics and health policy. While emphasis is placed on information with practical applications, a strong basis of underlying scientific rigor is maintained.
期刊最新文献
Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach. Quality-Adjusted Life Expectancy Norms Based on the EQ-5D-5L and SF-6Dv2 for China. Value is Gendered: The Need for Sex and Gender Considerations in Health Economic Evaluations. Assessing the Direct Impact of Death on Discrete Choice Experiment Utilities. Acknowledgement to Referees.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1